2009

December 2009

• "Regulation of NanoTechnology: Do the current rules fit?" 
• Christopher A, Bravery, PhD.
• Nanotechnology KTN: Nano-structure Materials in Tissue Engineering(NanoMITE).
• London, U.K.

November 2009

• "Overview of the regulation of advanced therapy medicinal products (ATMP) in the EU"  
• Christopher A, Bravery, PhD.
• RegeNer8 Annual Meeting. Translation of regenerative medicine into early phase trials and beyond.
• York, United Kingdom.

October 2009

• "What are ATMP's: Why do they require special scientific and regulatory attention?" 
• Christopher A, Bravery, PhD.
• Figon Dutch Medicine Days, Oct 12-14 2009. Developing Ground breaking New Treatments for Gene and Cell Therapy and Tissue Engineering.
• Lunteren, the Netherlands.